Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
(Q94863286)
scientific article published in April 2009
scientific article published in April 2009
Language:
Current Data About
Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
other details
description | scientific article published in April 2009 |
External Links
(P356) |
10.1517/13543780902832679
|
(P698) |
19335277
|